May 10th 2022, 10:30pm
On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.
May 10th 2022, 3:02pm
Drs Brinton and Slipczuk go into detail regarding an ideal multidisciplinary team for ASCVD treatment.
May 10th 2022, 2:58pm
Drs Riddock and Slipczuk define “optimal care” for ASCVD from a system-level perspective with the use of quality metrics.
May 3rd 2022, 4:27pm
Dr Eliot Brinton elaborates on unmet needs in lipid management and how they can be remedied.
May 3rd 2022, 4:21pm
Ian Riddock, MD, and Leandro N. Slipczuk, MD, PhD, discuss the importance of LDL-C management as part of the discharge plan for patients, as well as ensuring continuity of care from the inpatient to outpatient setting.
April 26th 2022, 4:49pm
Dr Brinton highlights the importance of adjunct therapies in LDL management.
April 26th 2022, 4:39pm
Dr Riddock explains how the ASCVD treatment landscape lends itself to initiation of therapy beyond statins in the inpatient setting.
April 20th 2022, 4:43pm
Eliot Brinton, MD, provides a warning concerning “maximally-tolerated statin dosing” and provides general guidance for optimal dosing.
April 20th 2022, 4:35pm
Ian Riddock, MD, describes the high-risk patient with ASCVD that is appropriate for early intensive lipid lowering.
April 8th 2022, 5:36pm
Ian Riddock, MD, describes residual cardiovascular risk, both with and without the use of statin therapies.
